tong, liangnan liu, danqing cao, zhiyue zheng, nannan mao, chenchen liu, shujuan liangcan, he liu, shaoqin
Gene therapy has attracted much attention because of its unique mechanism of action, non-toxicity, and good tolerance, which can kill cancer cells without damaging healthy tissues. siRNA-based gene therapy can downregulate, enhance, or correct gene expression by introducing some nucleic acid into patient tissues. Routine treatment of hemophilia req...
moreira, ana sofia bezemer, sandra faria, tiago q. detmers, frank hermans, pim sierkstra, laurens coroadinha, ana sofia peixoto, cristina
The use of viral vectors as therapeutic products for multiple applications such as vaccines, cancer treatment, or gene therapies, has been growing exponentially. Therefore, improved manufacturing processes are needed to cope with the high number of functional particles required for clinical trials and, eventually, commercialization. Affinity chroma...
faria, rúben boisguérin, prisca sousa, ângela costa, diana
Mitochondria are membrane-bound cellular organelles of high relevance responsible for the chemical energy production used in most of the biochemical reactions of cells. Mitochondria have their own genome, the mitochondrial DNA (mtDNA). Inherited solely from the mother, this genome is quite susceptible to mutations, mainly due to the absence of an e...
gaitsch, hallie hersh, andrew m. alomari, safwan tyler, betty m.
Novel therapeutic and diagnostic methods are sorely needed for gliomas, which contribute yearly to hundreds of thousands of cancer deaths worldwide. Despite the outpouring of research efforts and funding aimed at improving clinical outcomes for patients with glioma, the prognosis for high-grade glioma, and especially glioblastoma, remains dire. One...
godbout, kelly tremblay, jacques p.
Gene therapy holds tremendous potential in the treatment of inherited diseases. Unlike traditional medicines, which only treat the symptoms, gene therapy has the potential to cure the disease by addressing the root of the problem: genetic mutations. The discovery of CRISPR/Cas9 in 2012 paved the way for the development of those therapies. Improveme...
bringuier, claire mathilde noristani, harun najib perez, jean-christophe cardoso, maida goze-bac, christophe gerber, yannick nicolas perrin, florence evelyne
Spinal cord injury (SCI) leads to persistent neurological deficits without available curative treatment. After SCI astrocytes within the lesion vicinity become reactive, these undergo major morphological, and molecular transformations. Previously, we reported that following SCI, over 10% of resident astrocytes surrounding the lesion spontaneously t...
tseu, yi gloria wei kamaruzaman, khairul azfar
Breast cancer incidence and mortality rates have increased exponentially during the last decade, particularly among female patients. Current therapies, including surgery and chemotherapy, have significant negative physical and mental impacts on patients. As a safer alternative, gene therapy utilising a therapeutic gene with the potential to treat v...
Bao, Xiang-Hua Gao, Feng Athari, Seyyed Shamsadin Wang, Hongqun
Published in
Fundamental & clinical pharmacology
Asthma is a common respiratory disease that has no definitive treatment at now. Immune response shifting from T helper (Th)1 to the Th2 is a main problem in asthma, and immunomodulation can help to control asthma. IL-35 and mesenchymal stem cells (MSCs) have regulatory effect on the immune system and may have the ability to control asthma pathology...
lahlou, ghizlene calvet, charlotte giorgi, marie lecomte, marie-josé safieddine, saaid
Hearing loss, the most common human sensory defect worldwide, is a major public health problem. About 70% of congenital forms and 25% of adult-onset forms of deafness are of genetic origin. In total, 136 deafness genes have already been identified and there are thought to be several hundred more awaiting identification. However, there is currently ...
eleftheriou, androulla farmakis, dimitrios englezos, panos tuli, shobha mylona, elena constantinou, george elbard, riyad al-awadhi, saeed jafaar al-nahyan, bint seif ficarra, robert
...
Thalassaemia International Federation (TIF), representing the united voice of people with thalassaemia and their families globally, has been striving for more than three decades to empower research, by academic communities and industry, to focus on developing a safe and effective curative approach for thalassaemia. Such a cure would lead to new liv...